• UBS Group reported a 2.87% total voting rights stake in Qiagen, split between 1.62% held via shares and 1.25% via instruments.
• The position included 3.35 million shares, with additional exposure through swaps, call options, ordinary shares classified as potential, and convertible bonds.
• The disclosure related to a transaction dated May 18, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief via pressetext (Ref. ID: 202605221605PRESSTXTEUPR____95F6C8752339E095AEBCF8CD9AEE1EB) on May 22, 2026, and is solely responsible for the information contained therein.